P. Anderson

518 total citations
20 papers, 413 citations indexed

About

P. Anderson is a scholar working on Oncology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, P. Anderson has authored 20 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pharmacology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in P. Anderson's work include Cancer Treatment and Pharmacology (4 papers), Analytical Methods in Pharmaceuticals (4 papers) and Pharmacological Effects and Toxicity Studies (3 papers). P. Anderson is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Analytical Methods in Pharmaceuticals (4 papers) and Pharmacological Effects and Toxicity Studies (3 papers). P. Anderson collaborates with scholars based in Sweden and United Kingdom. P. Anderson's co-authors include Ulf Bondesson, Lars O. Boréus, L. O. Bor�us, Per‐Åke Hynning, H. Quiding, Carl‐Gunnar Swahn, Per Hartvig, O. Zetterström, Barbro Dahlén and B Johansson and has published in prestigious journals such as Clinical Chemistry, European Journal of Cancer and Journal of Internal Medicine.

In The Last Decade

P. Anderson

20 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Anderson Sweden 13 71 70 68 63 53 20 413
R. Calvo Spain 14 88 1.2× 65 0.9× 88 1.3× 39 0.6× 43 0.8× 47 538
T.B. Vree Netherlands 13 74 1.0× 117 1.7× 61 0.9× 49 0.8× 22 0.4× 29 504
Nahoko Kurosawa Japan 11 84 1.2× 33 0.5× 50 0.7× 68 1.1× 32 0.6× 30 427
L Sölvell Sweden 15 47 0.7× 75 1.1× 67 1.0× 59 0.9× 60 1.1× 31 655
CR Kumana Hong Kong 11 34 0.5× 45 0.6× 52 0.8× 55 0.9× 58 1.1× 36 354
Robert M. Stote United States 14 77 1.1× 130 1.9× 61 0.9× 40 0.6× 31 0.6× 25 702
V Khouw Canada 9 46 0.6× 49 0.7× 58 0.9× 66 1.0× 26 0.5× 14 321
R. F. Johnson United States 8 108 1.5× 54 0.8× 122 1.8× 39 0.6× 19 0.4× 15 474
W R McNabb United Kingdom 13 45 0.6× 38 0.5× 29 0.4× 92 1.5× 32 0.6× 23 536
Jeffrey W. Dubb United States 11 63 0.9× 133 1.9× 51 0.8× 143 2.3× 29 0.5× 17 626

Countries citing papers authored by P. Anderson

Since Specialization
Citations

This map shows the geographic impact of P. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Anderson more than expected).

Fields of papers citing papers by P. Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Anderson. The network helps show where P. Anderson may publish in the future.

Co-authorship network of co-authors of P. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of P. Anderson. A scholar is included among the top collaborators of P. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Anderson. P. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jonker, Renate, Nicolaas E.P. Deutz, Marcia L. Erbland, P. Anderson, & M.P. Engelen. (2013). OP013 WHOLE BODY DE NOVO ARGININE PRODUCTION AND NITRIC OXIDE SYNTHESIS ARE REDUCED IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Clinical Nutrition. 32. S5–S6. 1 indexed citations
2.
Venkatakrishnan, Karthik, Paul A. Meyers, Diane R. Mould, et al.. (2011). 9428 POSTER Pharmacokinetics and Pharmacodynamics of Liposomal Mifamurtide in Patients With Osteosarcoma. European Journal of Cancer. 47. S671–S671. 1 indexed citations
3.
Dahlén, Barbro, et al.. (1994). Plasma acetylsalicylic acid and salicylic acid levels during aspirin provocation in aspirin‐sensitive subjects. Allergy. 49(1). 43–49. 49 indexed citations
4.
Anderson, P., et al.. (1990). Nifedipine as an antihypertensive drug in patients with renal failure — pharmacokinetics and effects. Journal of Internal Medicine. 227(5). 329–337. 6 indexed citations
5.
Anderson, P., Lars O. Boréus, E. Gordon, et al.. (1989). Use of Mannitol During Neurosurgery. Survey of Anesthesiology. 33(6). 343–343. 1 indexed citations
6.
Anderson, P., L. O. Bor�us, E. Gordon, et al.. (1988). Use of mannitol during neurosurgery: Interpatient variability in the plasma and CSF levels. European Journal of Clinical Pharmacology. 35(6). 643–649. 20 indexed citations
7.
Hynning, Per‐Åke, P. Anderson, Ulf Bondesson, & Lars O. Boréus. (1988). Liquid-chromatographic quantification compared with gas-chromatographic-mass-spectrometric determination of verapamil and norverapamil in plasma.. Clinical Chemistry. 34(12). 2502–2503. 33 indexed citations
8.
Anderson, P., Ulf Bondesson, Ingrid Mattiasson, & B Johansson. (1987). Verapamil and norverapamil in plasma and breast milk during breast feeding. European Journal of Clinical Pharmacology. 31(5). 625–627. 29 indexed citations
9.
Quiding, H., P. Anderson, Ulf Bondesson, L. O. Bor�us, & Per‐Åke Hynning. (1986). Plasma concentrations of codeine and its metabolite, morphine, after single and repeated oral administration. European Journal of Clinical Pharmacology. 30(6). 673–677. 76 indexed citations
10.
Anderson, P., Ulf Bondesson, & Ulf dé Fairé. (1986). Pharmacokinetics of verapamil in patients with hypertension. European Journal of Clinical Pharmacology. 31(2). 155–163. 16 indexed citations
11.
Anderson, P., et al.. (1985). Pharmacokinetics and distribution of flucloxacillin in pacemaker patients. European Journal of Clinical Pharmacology. 27(6). 713–719. 13 indexed citations
12.
Anderson, P. & Carl‐Eric Elwin. (1985). Single-Dose Kinetics and Bioavailability of Sodium-Hydrogen Divalproate. Clinical Neuropharmacology. 8(2). 156–164. 3 indexed citations
13.
Hägermark, Ö, P. Anderson, & K. Nordlind. (1984). Failure of Mexiletine to Relieve Severe Pruritus. Dermatology. 169(4). 188–190. 3 indexed citations
14.
Anderson, P., et al.. (1984). Pharmacokinetics In Baclofen Overdose. Journal of Toxicology Clinical Toxicology. 22(1). 11–20. 36 indexed citations
15.
Anderson, P., et al.. (1982). Clinical pharmacokinetics of verapamil in patients with atrial fibrillation. European Journal of Clinical Pharmacology. 23(1). 49–57. 29 indexed citations
16.
Anderson, P., Ulf Bondesson, Christer Sylvén, & Hans Åström. (1982). Plasma Concentration-Response Relationship of Verapamil in the Treatment of Angina Pectoris. Journal of Cardiovascular Pharmacology. 4(4). 609–614. 28 indexed citations
17.
Anderson, P., Staffan Arnér, Ulf Bondesson, Lars O. Boréus, & Per Hartvig. (1982). Single‐Dose Kinetics and Bioavailability of Ketobemidone. Acta Anaesthesiologica Scandinavica. 26(s74). 59–62. 10 indexed citations
18.
Anderson, P., et al.. (1981). Clinical pharmacokinetics of bezafibrate in patients with impaired renal function. European Journal of Clinical Pharmacology. 21(3). 209–214. 12 indexed citations
19.
Anderson, P., Staffan Arnér, Ulf Bondesson, Lars O. Boréus, & Per Hartvig. (1981). Clinical pharmacokinetics of ketobemidone. Its bioavailability after rectal administration. European Journal of Clinical Pharmacology. 19(3). 217–223. 19 indexed citations
20.
Bondesson, Ulf, et al.. (1980). Clinical pharmacokinetics and oral bioavailability of ketobemidone. European Journal of Clinical Pharmacology. 17(1). 45–50. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Calvo Breakdown of academic impact, for papers by T.B. Vree Breakdown of academic impact, for papers by Nahoko Kurosawa Breakdown of academic impact, for papers by L Sölvell Breakdown of academic impact, for papers by CR Kumana Breakdown of academic impact, for papers by Robert M. Stote Breakdown of academic impact, for papers by V Khouw Breakdown of academic impact, for papers by R. F. Johnson Breakdown of academic impact, for papers by W R McNabb Breakdown of academic impact, for papers by Jeffrey W. Dubb
Rankless by CCL
2026